Yonsei University: Cardiomyopathies trials

The registry lists 14 Cardiomyopathies studies with Yonsei University as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 3 2Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Procedural Endpoint in Left Bundle Branch Area Pacing: Conduction System Capture Versus LV Septal CaptureNot yet recruitingNCT07804394Not applicable
• LBBAP vs. CS Pacing for CRT in Permanent Atrial Fibrillation and Heart Failure (SYNC-AF)Not yet recruitingNCT07560891Not applicable
• Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEFRecruitingNCT06978998
• Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited CardiomyopathyRecruitingNCT06948344
• Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringNot yet recruitingNCT06873828Phase 3
• ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathyRecruitingNCT06580717Phase 4
• Impact of MIgalastat TheRApy on CaRdiac Function in patiEnts With Fabry's Cardiomyopathy (MIRACRE-Fabry Trial)RecruitingNCT04639999
• The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy EraActive, not recruitingNCT05973591
• Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational StudyStatus unknownNCT05108168
• Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)Status unknownNCT04490681Phase 3
• Evaluation of the Improvement of Primary Prevention in Ischemic Cardiomyopathy Patients Using New Screening and Referring System (Advance-ICM)Status unknownNCT03590925
• Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's CardiomyopathyStatus unknownNCT03230591
• Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Trial)Status unknownNCT02469181
• Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic CardiomyopathyCompletedNCT01792960